Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Bisphosphonates evaluated in patients with metastatic breast cancer
October 13th, 2005
Bisphosphonates were evaluated in patients with metastatic breast cancer. According to recent research from Australia, "Bisphosphonate therapy has been readily accepted as standard of care for individuals with bone metastases from breast cancer. In this study we determined whether the proportion of patients experiencing a skeletal related event (SRE) in a clinical practice population was similar to that observed in phase III randomized controlled studies. A retrospective chart review was conducted of 110 patients receiving intravenous bisphosphonates for advanced breast cancer." "The proportion of patients experiencing at least one SRE after 12...
Source: Women's Health Weekly (2005-10-13)
|
